06.05.2024  15:24:33 Zm. - Wolumen Bid17:20:00 Ask17:20:00 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
0,90CHF - 5
Obrót: 4,52
-Wolumen Bid: - -Wolumen Ask: - 1,07 mldCHF - -

Opis działalności

Evolva Holding SA (formerly Arpida AG) is a Swiss synthetic biology company, internationally active in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva uses biosynthetic and evolutionary technologies to artificially create and optimise small molecule compounds and their production routes. Evolva’s products include stevia, resveratrol, vanillin, nootkatone and saffron. Evolva is active in consumer healthcare and nutrition as well as in pharma. In both areas they have partnered projects as well as own proprietary programmes.
 

Zarząd & Rada nadzorcza

CEO
Christian Wichert
Zarząd
Carsten Däweritz, Anne De Vos, Astrid Schäfer, Gerhard Lobmaier, Philipp Frech
Rada nadzorcza
Stephan Schindler, Beat In-Albon, Christoph Breucker, Andreas Pfluger, Andreas Weigelt
 

Dane firmy

Nazwa: Evolva Holding SA
Adres: Duggingerstraße 23,CH-4153 Reinach
Telefon: +41-61-485-2000
Fax: +41-61-485-2001
E-mail: info@evolva.com
Internet: www.evolva.com
Przemysł: Biotechnologia
Sektor: Biotechnologia
Podsektor: Biotechnologia
Koniec roku finansowego: 31.12
Free float: 69,53%
Data IPO: 26.04.2023

Relacje inwestorskie

Nazwa: Doris Rudischhauser
Telefon: +41-79-410-81-88
Fax: -
E-mail: dorisr@evolva.com

Główni akcjonariusze